Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
50
Number of overlapping holdings
65.8%
% of FXH's 77 holdings also in IXJ
44.6%
% of IXJ's 113 holdings also in FXH
Overlap by Weight
Sector Drift (FXH minus IXJ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FXH |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ABBOTT LABORATORIES | 1.9% | 3.3% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.9% | 1.8% | 1.8% |
|
AMGEN INC | 1.7% | 2.2% | 1.7% |
|
PFIZER INC | 1.7% | 1.8% | 1.7% |
|
ELI LILLY & CO | 1.5% | 9.6% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
FXH Overweight Relative to IXJ
|
PENUMBRA, INC. | 2.4% |
|
EXELIXIS INC | 2.4% |
|
DOXIMITY, INC. CLASS A | 2.2% |
|
UNITED THERAPEUTICS CORP | 2.2% |
|
TENET HEALTHCARE CORP | 2.2% |
|
MOLINA HEALTHCARE INC | 2.1% |
|
UNIVERSAL HEALTH SERVICES-B | 2.1% |
|
NATERA INC | 2.0% |
|
INSULET CORP | 2.0% |
 |
JAZZ PHARMACEUTICALS PLC | 1.9% |
FXH Underweight Relative to IXJ
|
ELI LILLY & CO | -8.1% |
|
JOHNSON & JOHNSON | -5.0% |
|
UNITEDHEALTH GROUP INC | -4.8% |
|
ABBVIE INC | -3.2% |
 |
ROCHE HOLDING LTD | -3.2% |
|
NOVARTIS AG | -3.2% |
 |
ASTRAZENECA PLC | -3.0% |
 |
NOVO NORDISK A/S-B | -2.9% |
|
MERCK & CO. INC. | -2.9% |
|
BOSTON SCIENTIFIC CORP | -2.0% |